Altamira Therapeutics Ltd.
Stock Forecast, Prediction & Price Target
Altamira Therapeutics Ltd. Financial Estimates
Altamira Therapeutics Ltd. Revenue Estimates
Altamira Therapeutics Ltd. EBITDA Estimates
Altamira Therapeutics Ltd. Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $63.88K N/A | $305.61K 378.40% | $0 -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $4.97M Low: $4.97M High: $4.97M avg. 0% | ||
Net Income
% change YoY
| $-17.39M N/A | $-26.52M -52.54% | $-7.27M 72.59% | Avg: $-1.34M Low: $-1.34M High: $-1.34M avg. 81.55% | Avg: $-747.21K Low: $-747.21K High: $-747.21K avg. 44.29% | ||
EBITDA
% change YoY
| $-17.02M N/A | $-26.01M -52.83% | $-1.35M 94.79% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $-995.41K Low: $-995.41K High: $-995.41K avg. 0% | ||
EPS
% change YoY
| -$525.13 N/A | -$582.58 -10.94% | -$14.81 97.45% | Avg: -$2.73 Low: -$2.73 High: -$2.73 avg. 81.56% | Avg: -$1.52 Low: -$1.52 High: -$1.52 avg. 44.29% | ||
Operating Expenses
% change YoY
| $14.92M N/A | $24.99M 67.48% | $6.53M -73.83% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $64.73M Low: $64.73M High: $64.73M avg. 0% | ||
FAQ
What is Altamira Therapeutics Ltd. stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 62.92% in 2025-2026.
We have gathered data from 1 analysts. Their low estimate is -1.34M, average is -1.34M and high is -1.34M.
What is Altamira Therapeutics Ltd. stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Altamira Therapeutics Ltd. stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 62.92% in 2025-2026.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.73, average is -$2.73 and high is $-2.73.